Scienture Holdings, Inc.
SCNX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001382574
No open-market purchases or sales by Scienture Holdings, Inc. insiders were filed in the last 90 days; 15 institutions reported holding it in 13F filings for Q2 2026, worth $709.1K in total; no superinvestor holds it.
Holders of 5% or more of SCNX
Holders whose latest Schedule 13D or 13G filing reports 5% or more of Scienture Holdings, Inc., largest stake first. The change is against the holder's previous filing.
No holder currently reports owning 5% or more of Scienture Holdings, Inc. on Schedule 13D or 13G.
Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.
13D and 13G filings
3 Schedule 13D and 13G filings on Scienture Holdings, Inc., newest first, including old-format filings without a stake.
| Filed (ET) | Filer | Form | Stake | Change | Event date | Filing |
|---|---|---|---|---|---|---|
| Nov 14, 20254:28 PM ET | L1 Capital Global Opportunities Master Fund, Ltd. | 13G/A | 0.00%0 shares | −5.55 ppfrom 5.55%Below 5% | Nov 14, 2025 | SEC |
| Aug 20, 20257:21 PM ET | Scoggin Management LPand 4 others | 13G | 0.01%150.0K shares | NewBelow 5% | Aug 14, 2025 | SEC |
| Aug 19, 20254:29 PM ET | L1 Capital Global Opportunities Master Fund, Ltd. | 13G | 5.55%1.07M shares | New | Aug 15, 2025 | SEC |
Form 144: proposed insider sales
Notices from officers, directors and other affiliates planning to sell Scienture Holdings, Inc. shares.
No Form 144 notices for Scienture Holdings, Inc. are on file.